CETIRIZINE HYDROCHLORIDE
NDC 16571-134, CETIRIZINE HYDROCHLORIDE, solution, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-134
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090191
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE1 mg/mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-134-12 | 16571013412 | 120 mL in 1 BOTTLE, PLASTIC (16571-134-12) |
| 16571-134-48 | 16571013448 | 480 mL in 1 BOTTLE, PLASTIC (16571-134-48) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/efabbad5-a162-45c8-a896-5af58e5d2d39NADAC price for package 16571013412
GET /v1/drugs/nadac/16571013412NADAC price for package 16571013448
GET /v1/drugs/nadac/16571013448
Use it
Look up 16571-134 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.